Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5656870 | Nutrition | 2017 | 15 Pages |
Abstract
In patients with CD, HMGB1 could represent a new marker that is able to reflect the immune impairment that results in failure of the HBV vaccination.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Sara M.D., Caterina M.D., Giuseppe F. M.D., Lucia M.D., Carmelo M.D., Salvatore M.D.,